AstraZeneca shares fall on report of potential China probe fallout
AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior executives at its China unit could be implicated in the largest insurance fraud case in the country's pharma sector in years.
(Yicai) Nov. 6 -- Major multinational automakers, including Volkswagen Group, Ford Motor, and Stellantis, reported disappointing sales in China in the quarter ended September as the country’s rapidly ...
AstraZeneca's shares have fallen more than 8% on speculation about an anti-corruption probe in China, its second-largest ...
AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...
AstraZeneca's (NASDAQ:AZN) selloff on Tuesday in response to reports that the company is facing a fraud investigation in ...
The AstraZeneca share price has fallen almost 25% since late August. Is there value on offer for investors after this huge ...
Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...
Shares plunged 8.4pc, the most in four years, after the report by Chinese state-owned news organisation Yicai claimed ...
Chinese electric vehicle maker Nio is planning to launch its first hybrid model in 2026 and will only sell it in overseas ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback